Cardiovascular outcomes after percutaneous coronary intervention on bifurcation lesions with moderate to severe

Jonathan Luke Murphy1, Nileshkumar Patel1, Yuliya Vengrenyuk1

  • 1Cardiovascular Institute, Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Insights

Complex coronary artery disease patients with both bifurcations and moderate/severe calcification face higher risks after percutaneous coronary intervention (PCI). This combination significantly increases major adverse cardiac events (MACE) risk compared to individual factors.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Percutaneous coronary intervention (PCI) outcomes are negatively impacted by target vessel calcification and bifurcation lesions.
  • The combined effect of these factors on PCI outcomes in complex coronary artery disease remains unclear.

Purpose of the Study:

  • To investigate the association of target vessel bifurcation and calcification, individually and combined, with adverse events post-PCI.
  • To assess the impact of these combined factors on major adverse cardiac events (MACE).

Main Methods:

  • Analysis of registry data from 21,165 patients undergoing PCI with drug-eluting stents (DES).
  • Patients categorized into four groups based on bifurcation presence and calcification severity (none/mild vs. moderate/severe).
  • Cox regression analysis used to evaluate 1-year MACE rates across groups.

Main Results:

  • The highest unadjusted rates of MACE, death, myocardial infarction (MI), and stent thrombosis occurred in patients with both bifurcation lesions and moderate/severe calcification.
  • Adjusted hazard ratios for MACE were significantly higher for patients with bifurcation and none/mild calcification (1.14), no bifurcation and moderate/severe calcification (1.21), and particularly for bifurcation with moderate/severe calcification (1.37) compared to the reference group.

Conclusions:

  • A bifurcating target vessel with moderate/severe calcification independently increases the risk of adverse outcomes post-PCI.
  • Novel strategies are required to mitigate risks and improve PCI outcomes in this high-risk patient subgroup with complex coronary artery disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
279
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
134
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
234
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
273